Improving access to good quality affordable medicines, diagnostic tests and vector control products to support malaria elimination in Asia Pacific by 2030. The Access to Quality Medicines and other Technologies Task Force (AQMTF) advise that improving access to health commodities and services was key to achieving malaria elimination in the region by 2030 and an essential element of enhanced regional health security.

Moving forward from the recommendations of the AQMTF, the APLMA Access Team and its partners in the pharmaceutical regulatory space are identifying and developing options to improve rapid access to new and current quality-assured health commodities for all in the Asia Pacific Region. Most of this work falls under the Regional Regulatory Partnership for Malaria Elimination which aims to strengthen national regulatory capacity and regional collaboration on pharmaceutical regulatory practices. The Access Team at APLMA works to support malaria elimination with the team’s activities encompassed within the 4A’s of Access : Availability, Affordability, Accessibility and Acceptability2.


Encouraging the production of quality medicines at the level of pharmaceutical manufacturers and facilitating the registration and distribution of these medicines to patients at the national level by:

  • Identifying priority commodities to control and manage malaria in the region based on WHO recommendations;
  • Strengthening the capacity of National Regulatory Authorities (NRAs) to register priority antimalarial commodities; and
  • Enhancing regional coordination and cooperation for the rapid registration of these commodities.


Facilitating quality commodities and services that are affordable to patients by:

  • Encouraging NRAs to facilitate quicker, and more cost-effective registration of antimalarial commodities;


Facilitating the availability of quality antimalarial commodities and services for all including hard-to-reach and mobile-migrant population by:

  • Supporting high level policy development that facilitates provision of services to all at risk populations;
  • Working with the private sector to expand the provision of services; and
  • Identifying best practices for last mile delivery.


Supporting the rational use of the appropriate quality commodities and promoting awareness of these within the community by;

  • Reducing the availability and use of medicines of Substandard and Falsified medicines;
  • Reducing the availability of treatments no longer recommended by the World Health Organization such as Oral Artemisinin Monotherapies; and
  • Strengthening the capacity of NRA to guarantee the quality of priority commodities along the supply and distribution chain;

Sign Up for APLMA Updates